Literature DB >> 2480167

Multiple sources of calcium for contraction of the human urinary bladder muscle.

C A Maggi1, S Giuliani, R Patacchini, D Turini, G Barbanti, A Giachetti, A Meli.   

Abstract

1. KCl, carbachol, neurokinin A and endothelin produced concentration-dependent contractions of mucosa-free muscle strips from the dome of the human urinary bladder. The maximal response to carbachol or neurokinin A exceeded that to KCl, while the maximal response to endothelin approached that to KCl. 2. Nifedipine (1 microM) abolished the response to KCl, reduced the response to carbachol or neurokinin A but had no effect on the response to endothelin. Bay K 8644 (1 microM) markedly potentiated the response to KCl but had little or no effect on the response produced by the other stimulants. 3. Superfusion of the strips with a nominally calcium (Ca)-free medium containing EDTA (1 mM) for 30 min markedly reduced the response to carbachol, neurokinin A and endothelin, although a small response was still evident at high concentrations. Likewise, after a prolonged (60 min) superfusion of the strips with a high K (80 mM) Ca-free medium plus EDTA (1 mM) these three agonists still produced a small contractile response. 4. The nifedipine (1 microM) resistant response to carbachol, neurokinin A or endothelin was markedly depressed by LaCl3 (1 mM). In contrast, the nifedipine-(1 microM) resistant response to carbachol was not modified by NiCl2 (0.1 mM) or omega-conotoxin (0.1 microM). 5. Caffeine produced divergent effects depending upon the temperature of incubation: a relaxation at 37 degrees C and a concentration-dependent (2.5-20 mM) contraction at 25 degrees C. The latter was markedly inhibited by procaine (3 mM) but unaffected by nifedipine (1 microM). 6. After a prolonged (60 min) superfusion with a high K, Ca-free medium containing EDTA the response to carbachol (100 microM) was abolished by previous exposure to procaine (3 mM). Conversely, the response to endothelin (1 microM) was unaffected by procaine. The response to endothelin in these experimental conditions was also resistant to LaCl3 (1 mM). 7. These findings indicate that multiple sources of Ca are mobilized for contraction of the human bladder muscle by different stimulants. Dihydropyridine- and voltage-sensitive Ca channels provide the major if not the sole source of Ca for the response to KCl, play some role in the response to muscarinic (carbachol) or NK-2 tachykinin receptor stimulation but are not involved in the response to endothelin. Carbachol, neurokinin A and endothelin all mobilize a Ca pool (either extracellular or located at membrane level) which is LaCl3-sensitive but nifedipine-resistant. Neither T- nor N-type channels appear to be involved in the response to carbachol. In addition, these agents mobilize a tightly bound Ca pool independently from membrane depolarization. This latter pool is probably a procaine-sensitive intracellular source of activator Ca mobilized by caffeine and carbachol. The failure of procaine to prevent the response to endothelin in high K, Ca-free medium raises the possibility that this peptide mobilizes an intracellular source of activator Ca, distinct from the caffeine- and carbachol-sensitive pool.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480167      PMCID: PMC1854771          DOI: 10.1111/j.1476-5381.1989.tb14634.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria.

Authors:  T Ishikawa; M Yanagisawa; S Kimura; K Goto; T Masaki
Journal:  Am J Physiol       Date:  1988-10

2.  Does endothelin mobilize calcium from intracellular store sites in rat aortic vascular smooth muscle cells in primary culture?

Authors:  N Miasiro; H Yamamoto; H Kanaide; M Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1988-10-14       Impact factor: 3.575

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

4.  Endothelin and Ca++ agonist Bay K 8644: different vasoconstrictive properties.

Authors:  M Auguet; S Delaflotte; P E Chabrier; E Pirotzky; F Clostre; P Braquet
Journal:  Biochem Biophys Res Commun       Date:  1988-10-14       Impact factor: 3.575

5.  Molecular mechanism of action of the vasoconstrictor peptide endothelin.

Authors:  C Van Renterghem; P Vigne; J Barhanin; A Schmid-Alliana; C Frelin; M Lazdunski
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

6.  Source of calcium for contractions induced by depolarization and muscarinic receptor stimulation in rabbit urinary bladder.

Authors:  S Batra; C Sjögren; K E Andersson; M Fovaeus
Journal:  Acta Physiol Scand       Date:  1987-08

7.  Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones.

Authors:  A P Fox; M C Nowycky; R W Tsien
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

8.  Contractile response of the human isolated urinary bladder to neurokinins: involvement of NK-2 receptors.

Authors:  C A Maggi; P Santicioli; R Patacchini; M Cellerini; D Turini; G Barbanti; P Beneforti; P Rovero; A Meli
Journal:  Eur J Pharmacol       Date:  1988-01-19       Impact factor: 4.432

9.  Endothelin action: Inhibition by a protein kinase C inhibitor and involvement of phosphoinositols.

Authors:  M Sugiura; T Inagami; G M Hare; J A Johns
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

10.  Caffeine-induced contraction in vascular smooth muscle.

Authors:  H Karaki; H Y Ahn; N Urakawa
Journal:  Arch Int Pharmacodyn Ther       Date:  1987-01
View more
  9 in total

1.  The contribution of intracellular Ca2+ release to contraction in human bladder smooth muscle.

Authors:  J G Masters; D E Neal; J I Gillespie
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Dependency of detrusor contractions on calcium sensitization and calcium entry through LOE-908-sensitive channels.

Authors:  J R Jezior; J D Brady; D I Rosenstein; K A McCammon; A S Miner; P H Ratz
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

3.  ATP induced-relaxation in the mouse bladder smooth muscle.

Authors:  B Boland; B Himpens; C Paques; R Casteels; J M Gillis
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

4.  Comparison of Bay K 8644, nitrendipine and atropine on spontaneous and pelvic-nerve-induced bladder contractions on rat bladder in vivo.

Authors:  W Diederichs; J Sroka; J Graff
Journal:  Urol Res       Date:  1992

5.  The direct effects of diethylstilboestrol and nifedipine on the contractile responses of isolated human and rat detrusor muscles.

Authors:  R A Elliott; C M Castleden; A Miodrag; P Kirwan
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  The role of extracellular Ca2+ in carbachol-induced tonic contraction of the pig detrusor smooth muscle.

Authors:  W Uchida; N Masuda; Y Shirai; K Shibasaki; N Satoh; T Takenada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

7.  Contractile activity of endothelin precursors in the isolated gallbladder of the guinea-pig: presence of an endothelin-converting enzyme.

Authors:  B Battistini; M Woods; L J O'Donnell; T D Warner; R Corder; A Fournier; M J Farthing; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro.

Authors:  G Edwards; M Henshaw; M Miller; A H Weston
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

9.  Characterization of endothelin (ET) receptors in the isolated gall bladder of the guinea-pig: evidence for an additional ET receptor subtype.

Authors:  B Battistini; L J O'Donnell; T D Warner; A Fournier; M J Farthing; J R Vane
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.